http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2128997-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_998f4e2d06a7c8fc1923c01400e170ba http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c031d6b4b6aa2aa6101bc45e377b5e8 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-194 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-616 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60 |
| filingDate | 1998-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1999-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c32a316c3d8d7f01cd7ba34dfaa0d10f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62aafd92a2287351480660d1072c6c0c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d724c7781f65a90124adfb75e0704d16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91bb17607026bd32a923ce96d4a0a903 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4663c7a28761ae6c23258881ae3da52 |
| publicationDate | 1999-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2128997-C1 |
| titleOfInvention | Soluble carbonated medicinal form of acetylsalicylic acid |
| abstract | FIELD: medicine, pharmacy. SUBSTANCE: proposed medicinal form of acetylsalicylic acid has acetylsalicylic acid, citric acid, succinic acid, alkaline metal carbonate and/or hydrocarbonate and an additional substance: water-soluble sugar taken from the order: lactose, glucose, sucrose taken at the definite ratio of components in mas. p. p. Also, composition can contain additionally ascorbic acid; binding agent: polyvinylpyrrolidone (molecular mass is 10000-40000 Da) or carboxymethylcellulose sodium; slipping substance: fumaric acid or benzoate sodium; sweetening agent - saccharin, saccharinate sodium or aspartam, and an aromatic principle also. Invention provides a possibility to use medicinal form of acetylsalicylic acid by patients suffering with different forms of diabetes mellitus, hypertension and other pathological states requiring limitation of sodium ions usage. EFFECT: improved quality of drug. 7 cl, 3 tbl, 20 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0174367-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1295601-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-012323-B1 |
| priorityDate | 1998-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 63.